Garcia Marino bought DNTH
March 12, 2026 · Form 4 insider transaction
Garcia Marino bought 122,918 shares of Dianthus Therapeutics, Inc. at $6.70 per share, a transaction worth $823.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
122,918
Price
$6.70
Total value
$823.6K
InsiderGarcia Marino
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after122,918
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025.